Back

DNA methylation patterns predict primary myocardial infarction

29 August 2026 (16:21 - 16:33)
Organised by: Logo
Congress Presentation Part of: Epigenetic and non-coding RNA regulation in cardiovascular disease Genetics, Epigenetics, ncRNA ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Markus Ingold

University Medical Centre of the Johannes Gutenberg University, Mainz (Germany)

4 More presentations in this session

Presentation thumbnail
EIciRNA CEROD upregulation exacerbates coronary artery calcification through promoting DHX36 ubiquitination
Mr R. Wang (Hefei, CN)
Abstract Slides Video
Presentation thumbnail
Landscape of protein l-lactylation in murine heart development: insights from proteomic analysis
Doctor Y. Li (Chongqing, CN)
Abstract Slides Video
Presentation thumbnail
Human SSA-lncWDR59 to reduce atherogenic adipose tissue and plaque progression
Doctor Z. Abedi Kichi (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Epigenetic activation of HMGCS2 by SETD7 drives metabolic remodeling and diastolic dysfunction in obese HFpEF
Doctor S. Mohammed (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Epigenetic and non-coding RNA regulation in cardiovascular disease
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 16:21 CET
You may be interested in
thumbnail
Congress Presentation
Identification of a DNA methylation signature for worsening of heart failure
30 August 2025
thumbnail
Congress Presentation
Cellular and spatial context of genetic risk in coronary artery disease
29 August 2026
thumbnail
Congress Session
Epidemiology: myocardial infarction and coronary artery
28 August 2026
thumbnail
Congress Presentation
Methylome of circulating cell free DNA as a novel biomarker tool: from acute coronary syndrome to broader risk stratification of cardiovascular disease
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources